Effect of fibromyalgia on bone mineral density in patients with fibromylagia and rheumatoid arthritis

dc.contributor.authorBuyukbese, M. A.
dc.contributor.authorPamuk, O. N.
dc.contributor.authorYurekli, O. A.
dc.contributor.authorYesil, N.
dc.date.accessioned2024-06-12T10:54:56Z
dc.date.available2024-06-12T10:54:56Z
dc.date.issued2013
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjectives: Fibromyalgia (FM) may t cause a decrease in bone mineral density (BMD) because of decreased mobility. The condition is relatively frequent in rheumatoid arthritis (RA) and RA patients with FM have more disability than those without FM. We evaluated the effect of FM on BMD and investigated the effect of FM on BMD in RA patients. Materials and Methods: We included age-matched 56 FM, 52 RA patients, and 37 healthy females as controls. Twenty three of all RA subjects met 1990 ACR FM criteria. Patients using the antiresorptive drugs, those on hormone replacement therapy, patients with thyroid or parathyroid dysfunction were excluded. Self-reported pain and fatigue severity, functional items of FM impact questionnaire were questioned in FM and RA patients. In all subjects, BMD of the lumbar spine and femur neck were determined by dual X-ray absorptiometry, and T-scores were recorded. Results: Self-reported pain and fatigue scores in FM subjects were significantly higher than in RA patients (P<0.001). The mean lumbar spine and femur neck BMD and their T-scores in RA patients were significantly lower than in FM and control groups (P values<0.01). There was no difference in BMD between FM subjects and the control group. BMD in RA patients with and without FM were similar (P>0.05). There was a significant negative correlation between self-reported pain score and lumbar spine BMD in FM subjects (r=-0.41, P=0.006). Conclusions: In spite of functional disability, FM does not cause a decrease in BMD. The presence of FM in RA patients does not result in a change in BMD.en_US
dc.identifier.doi10.4103/0022-3859.113825
dc.identifier.endpage109en_US
dc.identifier.issn0022-3859
dc.identifier.issue2en_US
dc.identifier.pmid23793310en_US
dc.identifier.scopus2-s2.0-84880909814en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage106en_US
dc.identifier.urihttps://doi.org/10.4103/0022-3859.113825
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19237
dc.identifier.volume59en_US
dc.identifier.wosWOS:000322250500005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMedknow Publications & Media Pvt Ltden_US
dc.relation.ispartofJournal Of Postgraduate Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBone Mineral Densityen_US
dc.subjectFibromyalgiaen_US
dc.subjectFibromyalgia Impact Questionnaireen_US
dc.subjectOsteoporosisen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectVitamin-D Deficiencyen_US
dc.subjectImpact Questionnaireen_US
dc.subjectDisease-Activityen_US
dc.subjectOsteoporosisen_US
dc.subjectClassificationen_US
dc.subjectValidationen_US
dc.subjectDisabilityen_US
dc.subjectCriteriaen_US
dc.subjectScoresen_US
dc.subjectMassen_US
dc.titleEffect of fibromyalgia on bone mineral density in patients with fibromylagia and rheumatoid arthritisen_US
dc.typeArticleen_US

Dosyalar